Keeping Track: Novartis Scores Big Ahead Of US Memorial Day With Approvals For Gene Therapy Zolgensma, Oncologic Piqray

 
• By Michael Cipriano, Brenda Sandburg, and Bridget Silverman
  
Keeping Track Feature image
Novartis stole the spotlight with the FDA's approval for its gene therapy Zolgensma.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet